Please Wait
Applying Filters...
menu
    • menu
    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-08-25

    Virtual Booth

    An Enquiry

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Zanubrutinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 47,911Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Europe Approves BeOne's BRUKINSA Tablet for All Indications
    Europe Approves BeOne's BRUKINSA Tablet for All Indications

    21 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250821182068/en/European-Commission-Approves-Tablet-Formulation-of-BeOne-Medicines-BRUKINSA-for-All-Approved-Indications

    BUSINESSWIRE
    21 Aug 2025
    Share Share
    BeOne Medicines gets CHMP Nod for Brukinsa tablet formulation
    BeOne Medicines gets CHMP Nod for Brukinsa tablet formulation

    25 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250623706166/en/BeOne-Medicines-Receives-Positive-CHMP-Opinion-for-Tablet-Formulation-of-BRUKINSA

    BUSINESSWIRE
    25 Jun 2025
    Share Share
    BeOne Medicines Presents Breakthrough Data in CLL and MCL at EHA
    BeOne Medicines Presents Breakthrough Data in CLL and MCL at EHA

    12 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250612215960/en/BeOne-Medicines-Showcases-Breakthrough-Data-in-CLL-and-MCL-at-EHA-2025

    BUSINESSWIRE
    12 Jun 2025
    Share Share
    Glenmark Pharma to launch DCGI-approved Brukinsa in India
    Glenmark Pharma to launch DCGI-approved Brukinsa in India

    11 Jun 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/glenmark-pharmaceuticals-to-launch-dcgi-approved-brukinsa-in-india-for-treatment-of-hematological-malignancies-17261

    INDPHARMAPOST
    11 Jun 2025
    Share Share
    U.S. Fda Approves Tablet Formulation of Brukinsa
    U.S. Fda Approves Tablet Formulation of Brukinsa

    11 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250611860939/en/U.S.-FDA-Approves-Tablet-Formulation-of-BeOnes-BRUKINSA-for-All-Approved-Indications

    BUSINESSWIRE
    11 Jun 2025
    Share Share
    BeOne Medicines Presents New SEQUOIA Study Results at ASCO 2025
    BeOne Medicines Presents New SEQUOIA Study Results at ASCO 2025

    31 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250531886517/en/BeOne-Medicines-Presents-New-SEQUOIA-Study-Results-Reinforcing-BRUKINSAs-Differentiated-Profile-with-or-without-Venetoclax-in-Frontline-CLL-at-ASCO-2025

    BUSINESSWIRE
    31 May 2025
    Share Share